{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:20:56Z","timestamp":1759191656320,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19046-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:43:50Z","timestamp":1759171430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Sophie","family":"Brunner-Ziegler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Staudacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sch\u00f6rgenhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Strasser-Marsik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Derhaschnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian B.","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"19046_CR1","doi-asserted-by":"crossref","unstructured":"Enthoven, W. T., Roelofs, P. D., Deyo, R. A., van Tulder, M. W. & Koes, B. W. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst. Rev., 2(2), Cd012087 (2016).","DOI":"10.1002\/14651858.CD012087"},{"issue":"9205","key":"19046_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(05)72163-2","volume":"355","author":"M Stubanus","year":"2000","unstructured":"Stubanus, M., Riegger, G. A., Kammerl, M. C., Fischereder, M. & Kr\u00e4mer, B. K. Renal side-effects of cyclo-oxygenase-type-2 inhibitor use. Lancet 355 (9205), 753 (2000).","journal-title":"Lancet"},{"issue":"4","key":"19046_CR3","first-page":"321","volume":"2","author":"JL Wallace","year":"1999","unstructured":"Wallace, J. L., Soldato, P. D., Cirino, G. & Muscar\u00e1, M. N. Nitric oxide-releasing nsaids: GI-safe antithrombotics. IDrugs 2 (4), 321\u2013326 (1999).","journal-title":"IDrugs"},{"issue":"2","key":"19046_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00045391-200007020-00011","volume":"7","author":"LF Prescott","year":"2000","unstructured":"Prescott, L. F. Paracetamol: past, present, and future. Am. J. Ther. 7 (2), 143\u2013147 (2000).","journal-title":"Am. J. Ther."},{"issue":"8","key":"19046_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0165-6147(99)01353-X","volume":"20","author":"P del Soldato","year":"1999","unstructured":"del Soldato, P., Sorrentino, R. & Pinto, A. NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol. Sci. 20 (8), 319\u2013323 (1999).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"19046_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","volume":"27","author":"M Levi","year":"1997","unstructured":"Levi, M., van der Poll, T., ten Cate, H. & van Deventer, S. J. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur. J. Clin. Invest. 27 (1), 3\u20139 (1997).","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"19046_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.CCM.0000297875.55969.DB","volume":"36","author":"FB Mayr","year":"2008","unstructured":"Mayr, F. B. et al. Duffy antigen modifies the chemokine response in human endotoxemia. Crit. Care Med. 36 (1), 159\u2013165 (2008).","journal-title":"Crit. Care Med."},{"issue":"5","key":"19046_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1086\/314717","volume":"179","author":"AF Suffredini","year":"1999","unstructured":"Suffredini, A. F., Hochstein, H. D. & McMahon, F. G. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J. Infect. Dis. 179 (5), 1278\u20131282 (1999).","journal-title":"J. Infect. Dis."},{"key":"19046_CR9","first-page":"99","volume":"159","author":"D van Lier","year":"2019","unstructured":"van Lier, D., Geven, C., Leijte, G. P. & Pickkers, P. Experimental Hum. Endotoxemia as Model. Systemic Inflamm. Biochimie, 159: 99\u2013106. (2019).","journal-title":"Experimental Hum. Endotoxemia as Model. Systemic Inflamm. Biochimie"},{"issue":"11","key":"19046_CR10","first-page":"801","volume":"24","author":"S Fiorucci","year":"2001","unstructured":"Fiorucci, S., Antonelli, E., Burgaud, J. L. & Morelli, A. Nitric Oxide\u2014Releasing NSAIDs Drug Saf., 24(11): 801\u2013811. (2001).","journal-title":"Nitric Oxide\u2014Releasing NSAIDs Drug Saf."},{"issue":"5","key":"19046_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/09537101003735572","volume":"21","author":"U Derhaschnig","year":"2010","unstructured":"Derhaschnig, U. et al. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia. Platelets 21 (5), 320\u2013328 (2010).","journal-title":"Platelets"},{"issue":"6","key":"19046_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0024-3205(95)02311-9","volume":"58","author":"B Jilma","year":"1996","unstructured":"Jilma, B. et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 58 (6), 469\u2013476 (1996).","journal-title":"Life Sci."},{"issue":"5","key":"19046_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00007890-199403150-00006","volume":"57","author":"E Roth","year":"1994","unstructured":"Roth, E. et al. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation 57 (5), 665\u2013669 (1994).","journal-title":"Transplantation"},{"issue":"1","key":"19046_CR14","doi-asserted-by":"publisher","first-page":"11180","DOI":"10.1038\/s41598-020-68125-9","volume":"10","author":"KD Kovacevic","year":"2020","unstructured":"Kovacevic, K. D. et al. The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by Desmopressin or endotoxin. Sci. Rep. 10 (1), 11180 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"19046_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1373\/clinchem.2003.022459","volume":"50","author":"G Endler","year":"2004","unstructured":"Endler, G. et al. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin. Chem. 50 (1), 195\u2013200 (2004).","journal-title":"Clin. Chem."},{"issue":"4","key":"19046_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1067\/mcp.2002.127740","volume":"72","author":"B Jilma","year":"2002","unstructured":"Jilma, B. et al. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin. Pharmacol. Ther. 72 (4), 403\u2013410 (2002).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"19046_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clpt.2005.10.003","volume":"79","author":"JM Leitner","year":"2006","unstructured":"Leitner, J. M. et al. Recombinant human antithrombin inhibits thrombin formation and Interleukin 6 release in human endotoxemia. Clin. Pharmacol. Ther. 79 (1), 23\u201334 (2006).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"19046_CR18","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1038\/s41598-019-47630-6","volume":"9","author":"C Schoergenhofer","year":"2019","unstructured":"Schoergenhofer, C. et al. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers. Sci. Rep. 9 (1), 11136 (2019).","journal-title":"Sci. Rep."},{"key":"19046_CR19","doi-asserted-by":"publisher","first-page":"30162","DOI":"10.1038\/srep30162","volume":"6","author":"B Thaler","year":"2016","unstructured":"Thaler, B. et al. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Sci. Rep. 6, 30162 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"19046_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/infdis\/171.1.145","volume":"171","author":"DB Kuhns","year":"1995","unstructured":"Kuhns, D. B., Alvord, W. G. & Gallin, J. I. Increased Circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J. Infect. Dis. 171 (1), 145\u2013152 (1995).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"19046_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/infdis\/163.1.89","volume":"163","author":"GA Spinas","year":"1991","unstructured":"Spinas, G. A., Bloesch, D., Keller, U., Zimmerli, W. & Cammisuli, S. Pretreatment with ibuprofen augments Circulating tumor necrosis Factor-\u03b1, Interleukin-6, and elastase during acute endotoxinemia. J. Infect. Dis. 163 (1), 89\u201395 (1991).","journal-title":"J. Infect. Dis."},{"issue":"6","key":"19046_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10194-010-0263-7","volume":"11","author":"O Summ","year":"2010","unstructured":"Summ, O., Andreou, A. P., Akerman, S. & Goadsby, P. J. A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches. J. Headache Pain. 11 (6), 477\u2013483 (2010).","journal-title":"J. Headache Pain"},{"issue":"1","key":"19046_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0009-9236(99)70053-6","volume":"66","author":"T Pernerstorfer","year":"1999","unstructured":"Pernerstorfer, T. et al. Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin. Pharmacol. Ther. 66 (1), 51\u201357 (1999).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"19046_CR24","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1097\/CCM.0b013e318186f5b2","volume":"36","author":"L H\u00e5llstr\u00f6m","year":"2008","unstructured":"H\u00e5llstr\u00f6m, L., Bergh\u00e4ll, E., Frostell, C., Sollevi, A. & Soop, A. L. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit. Care Med. 36 (11), 3043\u20133047 (2008).","journal-title":"Crit. Care Med."},{"key":"19046_CR25","doi-asserted-by":"crossref","unstructured":"Pompe, J. C., Kox, M., Hoedemaekers, C. W., van der Hoeven, J. G. & Pickkers, P. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia: it takes not always two to Tango. Crit. Care Med., 37(9), 2676\u20132677 (2009).","DOI":"10.1097\/CCM.0b013e3181aff67c"},{"issue":"4","key":"19046_CR26","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.4049\/jimmunol.0903107","volume":"184","author":"E Ricciotti","year":"2010","unstructured":"Ricciotti, E. et al. NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through Inhibition of I kappa B-alpha degradation in human monocytes. J. Immunol. 184 (4), 2140\u20132147 (2010).","journal-title":"J. Immunol."},{"issue":"10","key":"19046_CR27","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.4049\/jimmunol.155.10.5038","volume":"155","author":"AF Suffredini","year":"1995","unstructured":"Suffredini, A. F. et al. Effects of Recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155 (10), 5038\u20135045 (1995).","journal-title":"J. Immunol."},{"issue":"4","key":"19046_CR28","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1055\/s-0038-1657726","volume":"78","author":"B Jilma","year":"1997","unstructured":"Jilma, B. et al. Partial Blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man. Thromb. Haemost. 78 (4), 1268\u20131271 (1997).","journal-title":"Thromb. Haemost"},{"issue":"2","key":"19046_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0022-2143(98)90157-3","volume":"131","author":"B Jilma","year":"1998","unstructured":"Jilma, B. et al. Effects of Histamine and nitric oxide synthase Inhibition on plasma levels of von Willebrand factor antigen. J. Lab. Clin. Med. 131 (2), 151\u2013156 (1998).","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"19046_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0021-9150(99)00220-8","volume":"148","author":"T Pernerstorfer","year":"2000","unstructured":"Pernerstorfer, T., Stohlawetz, P., Kapiotis, S., Eichler, H. G. & Jilma, B. Partial Inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man. Atherosclerosis 148 (1), 43\u201347 (2000).","journal-title":"Atherosclerosis"},{"issue":"2","key":"19046_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1476-5381.2009.00343.x","volume":"158","author":"MM Curros-Criado","year":"2009","unstructured":"Curros-Criado, M. M. & Herrero, J. F. Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with Gabapentin. Br. J. Pharmacol. 158 (2), 601\u2013609 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"19046_CR32","doi-asserted-by":"crossref","unstructured":"Roy, R., Wilcox, J. & Webb, A. J. and K. O\u2019Gallagher, Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int. J. Mol. Sci. 24(20), 15200\u201315221 (2023).","DOI":"10.3390\/ijms242015200"},{"issue":"4","key":"19046_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.bjp.0706743","volume":"148","author":"CM Turnbull","year":"2006","unstructured":"Turnbull, C. M. et al. Mechanism of action of novel NO-releasing Furoxan derivatives of aspirin in human platelets. Br. J. Pharmacol. 148 (4), 517\u2013526 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"19046_CR34","doi-asserted-by":"publisher","first-page":"1176775","DOI":"10.3389\/fimmu.2023.1176775","volume":"14","author":"MJ Dorresteijn","year":"2023","unstructured":"Dorresteijn, M. J. et al. Atazanavir-induced unconjugated hyperbilirubinemia prevents vascular hyporeactivity during experimental human endotoxemia. Front. Immunol. 14, 1176775 (2023).","journal-title":"Front. Immunol."},{"issue":"4","key":"19046_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/clpt.2014.146","volume":"96","author":"AF Suffredini","year":"2014","unstructured":"Suffredini, A. F. & Noveck, R. J. Human endotoxin administration as an experimental model in drug development. Clin. Pharmacol. Ther. 96 (4), 418\u2013422 (2014).","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19046-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:43:52Z","timestamp":1759171432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19046-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19046-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33612"}}